Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Structured Breast Implant Outperforms Silicone Gel Implants Over Ten Years for Primary Augmentation

Ten-Year Data Shows Lower Risk of Rupture than Silicone Gel Implants as Surgeons Nationwide Report Higher Demand for IDEAL IMPLANT Structured Breast Implants


News provided by

Ideal Implant Incorporated

Jun 17, 2021, 11:15 ET

Share this article

Share toX

Share this article

Share toX

IDEAL IMPLANT Outperforms Silicone Gel Implants at 10 Years
IDEAL IMPLANT Outperforms Silicone Gel Implants at 10 Years
Youtube
Youtube

DALLAS, June 17, 2021 /PRNewswire-PRWeb/ -- Ideal Implant Incorporated today announced the release of its ten-year FDA Core Clinical Trial Data, indicating that the Structured Implant presents a substantially lower risk of two major breast implant complications compared to the silicone gel implants. While silicone gel implants have dominated the industry since they were allowed back on the market in 2006, technological advances over the past decade are now eliminating the need for accepting certain risks associated with silicone gel.

The cumulative risk of implant rupture or deflation with IDEAL IMPLANT over ten years after primary breast augmentation was only 3.7% in comparison to clinical trial data on silicone gel implants from Allergan (9.3%), Mentor (24.2%), and Sientra (8.7%) that had to use MRI scans to detect rupture. When a Structured Implant ruptures, a woman can easily detect partial deflation simply by looking in the mirror, and the multi-chamber design makes full deflation unlikely. Unlike silicone gel, any leaked saline is harmlessly absorbed by the body, and no MRI or ultrasound scan is necessary to detect a rupture.

We moved toward silicone gel implants after 2006 because they offered a better cosmetic result over the original, unstructured saline implants. Now we have the Structured Implant technology that offers the similar natural look without MRIs or silent rupture, and the safety of only saline inside."

Post this

"This data emphasizes a clear advance in breast implant technology where the old question to patients of 'do you want saline or silicone gel?' has become a false choice, since the original, unstructured saline implant does not offer natural results" reports Dr. Larry Nichter, a board-certified plastic surgeon in Southern California and an FDA investigator for the Structured Implant. "We moved toward silicone gel implants after 2006 because they offered a better cosmetic result over the original, unstructured saline implants. Now we have the Structured Implant technology that offers the similar natural look and feel as silicone gel and doesn't require MRI or ultrasound scans to detect rupture. It eliminates the concern of silent rupture and offers a significantly lower rupture risk, where the saline filler is safely absorbed by the body if there is a leak. In light of this ten-year clinical performance data, the question surgeons should now be asking patients today is, 'do you want Structured or silicone gel?'"

"Women seeking breast augmentation increasingly are demanding options that don't require silicone gel to be placed in their bodies, and they have less patience for the risk of silent rupture," reports Dr. Vivian Ting, a board-certified plastic surgeon in Northern California who presented survey data on women's implant preferences at the ASPS Aesthetica Super Symposium in 2018. "Too many surgeons—who are predominantly male in this industry—dismiss this trend simply because they are content with the options of the past. Hopefully this data will drive home that they will have fewer ruptures, better outcomes, and happier patients, when they stay current with the technology and patient preferences."

The IDEAL IMPLANT Structured Breast Implant also outperformed silicone gel implants over ten years in a second major breast implant complication: capsular contracture. After augmentation, the body may form scar tissue around the implant, which can deform the look of the breast and cause pain and firmness. Capsular contracture generally requires revision surgery to remove and replace the implant and scar tissue. IDEAL IMPLANT rates of Baker class III/IV capsular contracture over ten years after primary augmentation were only 6.6%, compared to silicone gel implants from Allergan (18.9%), Mentor (12.1%), and Sientra (12.9%).

"No woman wants to deal with breast implant complications, and this very low rate of capsular contracture directly translates to a lower risk of surgical revisions—and the expense and time associated with that," explains Dr. Elizabeth Kerner, a board-certified plastic surgeon in the Dallas Fort Worth Metroplex. "A year after surgery, I have to check a patient's chart to see whether they had silicone gel or the IDEAL IMPLANT, and in my experience, the look and feel is practically identical. While different implants are appropriate for different body types, IDEAL IMPLANT has now demonstrated a superior safety profile while offering the same look and feel as gel. I think we are already seeing this trend follow science as more women demand this choice."

Dr. Constance Barone, a renowned board-certified plastic surgeon with a busy practice in San Antonio, Texas, confirms this trend. "Demand for the IDEAL IMPLANT is high and growing quickly as women are more educated about the clinical performance data. I ensure all my patients see and feel each one of the current implant options and, almost exclusively these days, they pick the IDEAL IMPLANT."

The IDEAL IMPLANT Structured Breast Implant began FDA clinical trials in 2009, and received FDA and Health Canada approval for public use in 2014. The company also offers a first-of-its-kind optional Premium Protection Plan, which provides limited financial protection for certain complications related to the procedure and/or the implant, and is renewable for life for greater peace of mind. For more information, visit idealimplant.com.

Media Contact

Valerie Christensen, Ideal Implant Incorporated, +1 (971) 330-3649, [email protected]

Jodi Lewis, Ideal Implant Incorporated, (214) 212-6483, [email protected]

Twitter, Facebook

SOURCE Ideal Implant Incorporated

Related Links

http://idealimplant.com

Modal title

IDEAL IMPLANT Structured Implant Technology provides the look and feel of silicone gel without the compromises.
IDEAL IMPLANT Structured Implant Technology provides the look and feel of silicone gel without the compromises.
IDEAL IMPLANT - Patient Information Brochure
View PDF
IDEAL IMPLANT - Patient Information Brochure
IDEAL IMPLANT Structured Implant Technology provides the look and feel of silicone gel without the compromises. IDEAL IMPLANT - Patient Information Brochure

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.